return to news
  1. Upstox
    /
  2. News
    /
  3. Market News
    /
  4. Stocks
    /
  5. Stocks To Watch, February 11: Eicher Motors, Titan, Escorts Kubota, Cipla, Grasim

Market News

Stocks To Watch, February 11: Eicher Motors, Titan, Escorts Kubota, Cipla, Grasim

Abhishek Vasudev.jpg
By Abhishek Vasudev

4 min read | Updated on February 11, 2026, 08:35 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Titan clocked a total income of ₹25,567 crore during the quarter under review, marking a 43.09% YoY jump.

Stock list

GRASIM-RE
--
EICHERMOT
--
TITAN
--
Driven by State Bank of India (7.6%), IndusInd Bank (2.76%) and Kotak Mahindra Bank (1.28%), Nifty Bank jumped 1% to close at 60,669.35 on Monday. Image: Shutterstock

BSE shares will be in focus after its profit jumped nearly three times to ₹602 crore in December quarter. Image: Shutterstock

The Indian equity benchmarks are set to open higher on Wednesday as indicated by the NIFTY futures traded at Gift City. Gift NIFTY futures rose 69 points to 26,055, indicating a gap up opening for NIFTY50 index.

Open FREE Demat Account within minutes!
Join now
Here is a list of stocks that may remain in focus today.
Titan: The country's largest watch and jewellery retailer reported a 60.84% year-on-year (YoY) increase in its consolidated net profit to ₹1,684 crore. In the corresponding period of the previous fiscal year, it had logged a profit of ₹1,047 crore, the firm said in a regulatory filing.

Titan clocked a total income of ₹25,567 crore during the quarter under review, marking a 43.09% YoY jump from ₹17,868 crore in the third quarter of the 2024-25 fiscal year (Q3FY25).

Eicher Motors: The maker of Royal Enfield motorcycles reported a consolidated net profit of ₹1,421 crore in the third quarter of the current financial year, marking an increase of 21% from ₹1,170 crore in the same period last year. The company’s board also approved the capacity expansion plan.

The Delhi-based company's revenue from operations rose 23% to ₹6,114 crore in the October-December period from ₹4,973 crore in the year-ago period.

The company reported strong operational performance as its EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) jumped 30% to ₹1,557 crore from ₹1,201 crore. Its EBITDA margin improved by 130 basis points to 25.46%.

Eicher Motors' board gave its approval for the capacity expansion for Royal Enfield.

Escorts Kubota: The tractor manufacturer on Tuesday reported an 11.74% year-on-year (YoY) jump in its consolidated net profit to ₹358.29 crore.

In the corresponding period of the previous fiscal year, it had logged a profit of ₹320.64 crore, it said in a regulatory filing.

The firm recognised an incremental expense of approximately ₹52.46 crore relating to certain employees due to the implementation of the new labour code.

Its revenue from operations surged 11.23% YoY to ₹3,280.49 crore during the quarter under review, compared to ₹2,948.02 crore in the December quarter of the 2024-25 fiscal year (Q3FY25).

Grasim: Aditya Birla Group flagship holding firm Grasim Industries Ltd on Tuesday reported a 28.76% increase in its consolidated net profit to ₹2,232.95 crore for the December quarter of FY'26, led by a good performance across businesses.

The company had posted a net profit of ₹1,734.16 crore during the October-December quarter a year ago, according to a regulatory filing by Grasim Industries, which is the holding firm for group companies such as UltraTech, Aditya Birla Capital and Aditya Birla Renewables.

Its revenue from operations was up 25.25% to Rs ₹,311.97 crore in the December quarter under review. It was at ₹35,378.34 crore in the corresponding period of the previous fiscal.

Cipla: Drug maker Cipla said the US health regulator has issued Form 483 with two observations after inspecting a manufacturing facility of its US-based unit InvaGen Pharmaceuticals, Inc.

A Pre-Approval Inspection was conducted by the US Food and Drug Administration (USFDA) at the manufacturing facility of InvaGen from February 2 to February 9, 2026, the Mumbai-based drug maker said in a regulatory filing.

"On conclusion of the inspection, InvaGen has received two inspectional observations in Form 483. The company will work closely with the USFDA and is committed to address these comprehensively within stipulated time," it added.

Dilip Buildcon: Multi-asset infrastructure developer Dilip Buildcon Ltd (DBL) on Tuesday reported a profit of ₹789 crore for the October-December quarter of FY2025-26, boosted by a one-time gain.

The company had reported a profit of ₹158 crore in the corresponding quarter of the last year, according to an exchange filing.

The quarterly performance was supported by exceptional income of ₹585 crore, arising from the transfer of equity interests in seven Hybrid Annuity Model (HAM) road assets from DBL to the InvIT, a company statement said.

Britannia Industries: Bakery food company Britannia Industries on reported a 17.14% rise in consolidated net profit to ₹682.14 crore for the December quarter of FY26, driven by strong momentum across both the biscuits and adjacent categories.

The company had posted a net profit of ₹582.3 crore in the October-December quarter a year ago, according to a regulatory filing from Britannia Industries.

Its revenue from operations was up 8.21% to ₹4,969.82 crore in the third quarter of FY'26. It was at ₹4,592.62 crore in the corresponding quarter.

Britannia’s total expenses were at ₹4,107.59 crore, up 6% in Q3/FY26.

Total income of Britannia, which includes other income, in the December quarter was up 8% to ₹5,029.28 crore.

(With PTI inputs)
Disclaimer: This article is purely for informational purposes and should not be considered investment advice from Upstox. Please consult with a financial advisor before making any investment decisions.

About The Author

Abhishek Vasudev.jpg
Abhishek Vasudev is a business journalist with over 15 years of experience covering business and markets. He has worked for leading media organisations of the country.

Next Story